Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Prostatic Neoplasms 2 Polycystic Ovary Syndrome 2 Uterine Cervical Dysplasia 1 Urinary Bladder Neoplasms 1 Stomatitis 1 Sarcopenia 1 Precancerous Conditions 1 Papillomavirus Infections 1 Pain 1 Leukemia 1 Infections 1 Healthy 1 Fatty Liver 1 Colorectal Neoplasms 1

Interventions

Resistance Training 6 Exercise 5 Ultrasonography 3 Docosahexaenoic Acids 3 maltodextrin 2 Walking Speed 2 Tomography, X-Ray Computed 2 Nutrition Assessment 2 Hand Strength 2 Gastrectomy 2 Esophagectomy 2 Drug Therapy 2 pembrolizumab 1 nicotinamide-beta-riboside 1 fucoidan 1 durvalumab 1 atezolizumab 1 Whey Proteins 1 Wearable Electronic Devices 1 Testosterone 1 Standard of Care 1 Soybean Proteins 1 Relaxation Therapy 1 Preoperative Exercise 1 Olive Oil 1 Nutritional Status 1 Nutrition Therapy 1 Nivolumab 1 Immunotherapy 1 Immune Checkpoint Inhibitors 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Sarcopenia × Olive Oil × Clear all

NCT02779868 2017-07-25

Omega-3 Supplementation in Cervix Cancer Patients Undergoing Chemoradiotherapy

Brazilian National Cancer Institute

Phase NA Completed

Sarcopenia

Data powered by HemOnc (CC BY 4.0) Colophon ⚡